Detection of Trastuzumab Related Cardiotoxicity in Taiwanese Breast Cancer Women

被引：0
|
作者：
Chien, Hsu-Chih [1 ,2 ]
Cheng, Ching-Lan [1 ,2 ,3 ]
Lee, Cheng-Han [4 ]
Bai, Jane P. F. [5 ]
Yang, Yea-Huei Kao [1 ,2 ,3 ]
机构：
[1] Natl Cheng Kung Univ, Coll Med, Inst Clin Pharm & Pharmaceut Sci, Tainan, Taiwan
[2] Natl Cheng Kung Univ, Hlth Outcome Res Ctr, Tainan, Taiwan
[3] Natl Cheng Kung Univ, Sch Pharm, Coll Med, Tainan, Taiwan
[4] Natl Cheng Kung Univ Hosp, Div Cardiol, Tainan, Taiwan
[5] US FDA, Off Clin Pharmacol, Off Translat Sci, Ctr Drug Evaluat & Res, Silver Spring, MD USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2016年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
607
引用
收藏
页码：354 / 354
页数：1
相关论文
共 50 条
  • [21] Trastuzumab related cardiotoxicity in nonmetastatic breast cancer: A real-world scenario
    Shrivastva, S.
    Prasad, S. K.
    Chennamaneni, R.
    Stalin, B.
    Konatam, M. L.
    Gundeti, S.
    ANNALS OF ONCOLOGY, 2019, 30
  • [22] Diabetes and breast cancer in Taiwanese women: a detection bias?
    Tseng, Chin-Hsiao
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2014, 44 (10) : 910 - 917
  • [23] Cardiotoxicity in elderly breast cancer patients in treatment with trastuzumab
    Mocerino, C.
    Cacciapuoti, F.
    Caruso, G.
    Taddeo, M.
    Gambardella, A.
    GIORNALE DI GERONTOLOGIA, 2011, 59 (03) : 140 - 146
  • [24] THE IMPACT OF CARDIOTOXICITY AND TRASTUZUMAB INTERRUPTION ON BREAST CANCER OUTCOMES
    Copeland-Halperin, Robert
    Al-Sadawi, Mohammed
    Patil, Sujata
    Yadav, Nandini
    Liu, Jennifer E.
    Dang, Chau
    Steingart, Richard
    Yu, Anthony F.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 741 - 741
  • [25] Cardiotoxicity of concomitant radiotherapy and trastuzumab for early breast cancer
    Marinko, Tanja
    Dolenc, Jure
    Bilban-Jakopin, Cvetka
    RADIOLOGY AND ONCOLOGY, 2014, 48 (02) : 105 - 112
  • [26] Anthracycline and trastuzumab-induced cardiotoxicity in breast cancer
    Nicolazzi, M. A.
    Carnicelli, A.
    Fuorlo, M.
    Scaldaferri, A.
    Masetti, R.
    Landolfi, R.
    Favuzzi, A. M. R.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (07) : 2175 - 2185
  • [27] Cardiotoxicity associated with the use of trastuzumab in breast cancer patients
    Perik, Patrick J.
    de Korte, Maarten Alexander
    van Veldhuisen, Dirk J.
    Gietema, Jourik A.
    Sleijfer, Dirk T.
    de Vries, Elisabeth G. E.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2007, 7 (12) : 1763 - 1771
  • [28] Trastuzumab cardiotoxicity in early-stage breast cancer
    Burki, Talha Khan
    LANCET ONCOLOGY, 2016, 17 (06): : E226 - E226
  • [29] Factors Predicting Trastuzumab-related Cardiotoxicity in a Real-world Population of Women with HER2+ Breast Cancer
    Naumann, David
    Rusius, Victoria
    Margiotta, Chiara
    Nevill, Alan
    Carmichael, Amtul
    Rea, Daniel
    Sintler, Martin
    ANTICANCER RESEARCH, 2013, 33 (04) : 1717 - 1720
  • [30] Trastuzumab-related cardiotoxicity in patients with breast cancer with comorbidities of obesity, dyslipidemia, and diabetes.
    Aseyev, Olexiy
    Johnson, Christopher
    Turek, Michele
    Law, Angeline
    Sulpher, Jeffrey Allen
    Dent, Susan Faye
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345